M. Pullen

发表

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.

David M. Liebovitz, N. Sherwood, D. Boulware, 2022, The New England journal of medicine.

Blastomycosis—Some Progress but Still Much to Learn

N. Bahr, Jonathan D. Alpern, M. Pullen, 2022, Journal of fungi.

Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus–Associated Tuberculous Meningitis

D. Boulware, F. Cresswell, A. Bangdiwala, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra PCR Cycle Threshold value predicts two-week mortality in HIV-associated tuberculous meningitis

D. Boulware, F. Cresswell, A. Bangdiwala, 2020 .

CSF early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials.

D. Boulware, K. H. Hullsiek, G. Meintjes, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial

J. Balko, S. Lofgren, D. Boulware, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial

J. Balko, S. Lofgren, D. Boulware, 2020, medRxiv.

Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)

Emily G McDonald, David R Boulware, Oriol Mitjà, 2020, Open forum infectious diseases.

Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials

S. Lofgren, D. Boulware, K. H. Hullsiek, 2021, Open forum infectious diseases.

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Emily G McDonald, Ananta S Bangdiwala, David R Boulware, 2020, The New England journal of medicine.

Symptoms of COVID-19 Outpatients in the United States

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Open forum infectious diseases.

Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Open forum infectious diseases.

Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, medRxiv.

Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up

David M. Liebovitz, D. Boulware, D. Odde, 2022, medRxiv.

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Annals of Internal Medicine.

Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Open forum infectious diseases.

Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial

David M. Liebovitz, N. Sherwood, D. Boulware, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: Study Protocol for a Pragmatic Randomized Controlled Trial

S. Lofgren, D. Boulware, K. H. Hullsiek, 2020, medRxiv.

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

David M. Liebovitz, N. Sherwood, M. Rose, 2023, The Lancet Infectious Diseases.

Patient-facing job role is associated with SARS-CoV-2 positivity among healthcare workers in long term care facilities in Minnesota, August-December, 2020.

J. Mulcahy, M. Pullen, R. Bakare, 2023, Infection control and hospital epidemiology.

The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial

M. Rich, J. Schiffer, D. Boulware, 2023, Open forum infectious diseases.

Tuberculosis at the animal–human interface in the Ugandan cattle corridor using a third-generation sequencing platform: a cross-sectional analysis study

D. Boulware, S. Sreevatsan, M. F. Pullen, 2019, BMJ Open.

Change in plasma CrAg titer is not associated with survival among HIV-infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia.

D. Boulware, A. Kiragga, Y. Manabe, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.

A. Ginde, D. Boulware, Krista K. Vermillion, 2023, JAMA.

Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial

David M. Liebovitz, Tejas Mehta, D. Boulware, 2023, medRxiv.

Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply.

David M. Liebovitz, N. Sherwood, D. Boulware, 2022, The New England journal of medicine.